Spearhead Capital Advisors’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History
Bought
Maintained
Sold
Other funds holding SWAV
GGHC
Spearhead Capital Advisors's SWAV Position: Q3 2022 in Review
Spearhead Capital Advisors reduced its Shockwave Medical, Inc. Common Stock (SWAV) stake by 55% in Q3 2022, selling an estimated $229K and leaving 752 shares worth $209K. The position accounts for 0.23% of the portfolio, ranked #94.
Spearhead Capital Advisors first reported a position in SWAV in Q1 2022 and has held it in 3 quarters since. The position peaked at $348K in Q1 2022. 412 funds tracked by Wall St. Rank hold SWAV as of Q3 2022.
- Spearhead Capital Advisors held 752 shares of Shockwave Medical, Inc. Common Stock worth $209K as of Q3 2022.
- Spearhead Capital Advisors sold 902 Shockwave Medical, Inc. Common Stock shares in Q3 2022, an estimated $229K.
- Shockwave Medical, Inc. Common Stock made up 0.23% of Spearhead Capital Advisors's portfolio in Q3 2022, its #94 holding.
- Spearhead Capital Advisors first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2022 and has held it in 3 quarters since.
- Spearhead Capital Advisors's Shockwave Medical, Inc. Common Stock position peaked at $348K in Q1 2022.
- 412 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q3 2022.
Based on Spearhead Capital Advisors's 13F filing for Q3 2022, filed 9 Nov 2022.